Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AZ Bets Big On ADCs As It Inks Second, $6bn Deal With Daiichi

$1bn Upfront To Secure New Asset

Jul 27 2020

• By Ian Haydock

Flag of Great Britain and Japan - Illustration — AZ, Daiichi Enter Into Second Major Oncology Alliance • Source: Shutterstock

Related Content

First Filing, In Japan, For Daiichi’s Lead ADC As Others Progress

Sep 13 2019

Immunomedics' Trodelvy Will Be First ADC For Triple-Negative Breast Cancer

Apr 23 2020

Boost For Daiichi's Oncology Ambitions As AZ Agrees Huge $6.9bn Deal For Lead ADC Asset

Mar 29 2019

Related Companies

AstraZeneca PLC

Daiichi Sankyo Co., Ltd.

Immunomedics, Inc.

Additional Topics

Commercial Deals Cancer BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window